Wayland Group Corp. produces and sells medical marijuana in Canada and internationally. The company was founded in 2013 and is based Burlington, Canada.
Wayland Group reported revenue of 3.22 million CAD for fiscal year 2017, down 20.6% from fiscal year 2016, and net income of -67.01 million CAD. In Q3 2018 (the quarter ended September 30, 2018) revenue was 225,122 CAD, down 68.8% from a year before.
Figures from company filings; latest fiscal year ended December 31, 2017.
No profile data available.